References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. https://doi.org/10.3322/caac.21492
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
- Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303-316. https://doi.org/10.4143/crt.2018.143
- Eileen M. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1-17. https://doi.org/10.1128/CMR.16.1.1-17.2003
- Maucort-Boulch D, Franceschi S, Plummer M. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev. 2008;17:717-720. https://doi.org/10.1158/1055-9965.EPI-07-2691.
- Wentzensen N, Arbyn M. HPV-based cervical cancer screening-facts, fiction, and misperceptions. Prev Med. 2017;98: 33-35. https://doi.org/10.1016/j.ypmed.2016.12.040.
- Park SM, Lee SK, Kim YS. Inhibition of cervical cancer cell growth by gene silencing of HPV16 E6 induced by short-interfering RNA. Korean J Clin Lab Sci. 2011;43:89-97.
- Baptista AD, Simao CX, Santos VCGD, Melgaco JG, Cavalcanti SMB, Fonseca SC, et al. Knowledge of human papillomavirus and Pap test among Brazilian university students. Rev Assoc Med Bras. 2019;65:625-632. https://doi.org/10.1590/1806-9282.65.5.625.
- Watson M, Benard V, King J, Crawford A, Saraiya M. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey. Prev Med. 2017;100:243-247. https://doi.org/10.1016/j.ypmed.2017.05.004.
- Al-Nourhji O, Dermawan JK, Booth CN, Underwood D, Abdul-Karim FW. Role of ThinPrep liquid-based cytology in evaluation of the endocervical canal in patients with abnormal cervical screening. J Am Soc Cytopathol. 2019;8:278-283. https://doi.org/10.1016/j.jasc.2019.05.001.
- Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol. 2015;123:271-281. https://doi.org/10.1002/cncy.21521.
- Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;10:8:CD008587. https://doi.org/10.1002/14651858.CD008587.pub2.
- El-Zein M, Richardson L, Franco EL. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. J Clin Virol. 2016;76(Suppl 1):S62-S68. https://doi.org/10.1016/j.jcv.2015.11.020.
- Pruski D, Millert-Kalinska S, Lewek A, Kedzia W. Sensitivity and specificity of HR HPV E6/E7 mRNA test in detecting cervical squamous intraepithelial lesion and cervical cancer. Ginekol Pol. 2019;90:66-71. https://doi.org/10.5603/GP.2019.0011.
- Park SY, Yoon HS, Bang HE, Kim Y, Cho SK, Ahn SW, et al. Analytical performance of sensitivity and specificity for rapid multiplex high risk human papillomavirus detection kit: HPV ViroCheck. Korean J Clin Lab Sci. 2017;49:446-454. https://doi.org/10.15324/kjcls.2017.49.4.446
- Poljak M, Kocjan BJ, Ostrbenk A, Seme K. Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. J Clin Virol. 2016;76(Suppl 1):3-13. https://doi.org/10.1016/j.jcv.2015.10.023.
- Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med. 2007;11:881-891. https://doi.org/10.1111/j.1582-4934.2007.00073.x
- Kim GH, Park SY, Wang HY, Kim SH, Park SJ, Yu KM, et al. Distribution of oncogenic human papillomavirus genotypes at high grade cervical lesions above CIN 2 grade with histological diagnosis. Biomed Sci Lett. 2016;22:98-106. https://doi.org/10.15616/BSL.2016.22.3.98
- Roberts CC, Swoyer R, Bryan JT, Taddeo FJ. Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection. J Clin Microbiol. 2011;49:1899-1906. https://doi.org/10.1128/JCM.00235-10.
-
Pasquier C, Saune K, Raymond S, Boisneau J, Courtade M, Izopet J. Comparison of Cobas(R) HPV and
$Anyplex^{TM}$ II HPV28 assays for detecting and genotyping human papillomavirus. Diagn Microbiol Infect Dis. 2017;87:25-27. https://doi.org/10.1016/j.diagmicrobio.2016.08.022. - Pan C, Zhou J, Lyu J, Ren X. Development and validation of a multiplex reverse transcript real-time PCR for E6/E7 mRNA detection of high-risk human papillomavirus. J Med Microbiol. 2018;67:1509-1514. https://doi.org/10.1099/jmm.0.000824.
- Sahiner F, Kubar A, Yapar M, Sener K, Dede M, Gumral R. Detection of major HPVs by a new multiplex real-time PCR assay using type-specific primers. J Microbiol Methods. 2014;97:44-50. https://doi.org/10.1016/j.mimet.2013.12.012.
- Yang H, Li LJ, Xie LX, Luo ZY, Lu M, Lin M, et al. Clinical validation of a novel real-time human papillomavirus assay for simultaneous detection of 14 high-risk HPV type and genotyping HPV type 16 and 18 in China. Arch Virol. 2016;161:449-454. https://doi.org/10.1007/s00705-015-2673-y.
- Micalessi IM, Boulet GA, Bogers JJ, Benoy IH, Depuydt CE. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med. 2011;50:655-661. https://doi.org/10.1515/cclm.2011.835.
- Harvey RJ, Darlison MG. Random-primed cDNA synthesis facilitates the isolation of multiple 5'-cDNA ends by RACE. Nucleic Acids Res. 1991;19:4002. https://doi.org/10.1093/nar/19.14.4002.
- Michaelidou K, Tzovaras A, Missitzis I, Ardavanis A, Scorilas A. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int J Oncol. 2013;42:1770-1777. https://doi.org/10.3892/ijo.2013.1860.
- Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics. 2006;7:85. https://doi.org/10.1186/1471-2105-7-85.
- Picard-Meyer E, Peytavin de Garam C, Schereffer JL, Marchal C, Robardet E, Cliquet F. Cross-platform evaluation of commercial real-time SYBR green RT-PCR kits for sensitive and rapid detection of European bat Lyssavirus type 1. Biomed Res Int. 2015;2015:839518. https://doi.org/10.1155/2015/839518.
- Kim GH, Cho HM, Lee DS, Park SY, Lee JY, Wang HY, et al. Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer. Exp Mol Pathol. 2017;102:321-326. https://doi.org/10.1016/j.yexmp.2017.02.015.
- Wang HY, Lee DS, Park SY, Kim GH, Kim SH, Han L, et al. Diagnostic performance of HPV E6/E7 mRNA and HPV DNA assays for the detection and screening of oncogenic human papillomavirus infection among woman with cervical lesions in China. Asian Pac J Cancer Prev. 2015;16:7633-7640. https://doi.org/10.7314/APJCP.2015.16.17.7633
- Wang HY, Park SY, Lee DS, Kim SH, Kim GH, Park KH, et al. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions. Int J Infect Dis. 2015;37:135-142. https://doi.org/10.1016/j.ijid.2015.06.018.
- Buzard GS, Baker D, Wolcott MJ, Norwood DA, Dauphin LA. Multi-platform comparison of ten commercial master mixes for probe-based real-time polymerase chain reaction detection of bioterrorism threat agents for surge preparedness. Forensic Sci Int. 2012;223:292-297. https://doi.org/10.1016/j.forsciint.2012.10.003.
- Wacker MJ, Godard MP. Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J Biomol Tech. 2005;16:266-271.
- Jacob F, Guertler R, Naim S, Nixdorf S, Fedier A, Hacker NF, et al. Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines. PLoS One. 2013;8:E59180. https://doi.org/10.1371/journal.pone.0059180.
- Pfaffl M. Quantification strategies in real-time PCR. In: Bustin S, editor. A-Z of Quantitative PCR. chapter 3. La Jolla, CA, USA: International University Line; 2004; p. 87-112.
- Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol. 1987;61:962-971. https://doi.org/10.1128/JVI.61.4.962-971.1987
- Lie AK1, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R, Onsrud M, Thoresen S. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol. 2005;97:908-915. https://doi.org/10.1016/j.ygyno.2005.02.026.
Cited by
- Triglyceride Down-regulates Expression of MSR-1 in PMA-induced THP-1 Macrophages vol.26, pp.3, 2020, https://doi.org/10.15616/bsl.2020.26.3.164
- Circular RNA MAT2B promotes migration, invasion and epithelial-mesenchymal transition of non-small cell lung cancer cells by sponging miR-431 vol.20, pp.16, 2019, https://doi.org/10.1080/15384101.2021.1956106